124 related articles for article (PubMed ID: 18446267)
21. Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity.
Bodur H; Borman P; Ozdemir Y; Atan C; Kural G
Clin Rheumatol; 2006 May; 25(3):329-33. PubMed ID: 16267609
[TBL] [Abstract][Full Text] [Related]
22. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
[TBL] [Abstract][Full Text] [Related]
23. Genital ulcer severity score and genital health quality of life in Behçet's disease.
Senusi A; Seoudi N; Bergmeier LA; Fortune F
Orphanet J Rare Dis; 2015 Sep; 10():117. PubMed ID: 26394620
[TBL] [Abstract][Full Text] [Related]
24. Correlation of clinical signs and symptoms of Behçet's disease with mean platelet volume (MPV) and red cell distribution width (RDW).
Masoumi M; Shadmanfar S; Davatchi F; Shahram F; Akhlagi M; Faezi T; Kavosi H; Moradi S; Balasi J
Orphanet J Rare Dis; 2020 Oct; 15(1):297. PubMed ID: 33087144
[TBL] [Abstract][Full Text] [Related]
25. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
26. Decreased protein S activity is related to the disease activity of Behcet's disease.
Kwon SR; Lim MJ; Park SG; Moon YS; Park W
Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634
[TBL] [Abstract][Full Text] [Related]
27. The relationship between disease activity and depression and sleep quality in Behçet's disease patients.
Koca I; Savas E; Ozturk ZA; Tutoglu A; Boyaci A; Alkan S; Kisacik B; Onat AM
Clin Rheumatol; 2015 Jul; 34(7):1259-63. PubMed ID: 24816545
[TBL] [Abstract][Full Text] [Related]
28. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.
Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M
Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990
[TBL] [Abstract][Full Text] [Related]
29. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.
Davatchi F; Sadeghi Abdollahi B; Tehrani Banihashemi A; Shahram F; Nadji A; Shams H; Chams-Davatchi C
Mod Rheumatol; 2009; 19(5):542-9. PubMed ID: 19597921
[TBL] [Abstract][Full Text] [Related]
30. Birmingham Behçet's service: classification of disease and application of the 2014 International Criteria for Behçet's Disease (ICBD) to a UK cohort.
Blake T; Pickup L; Carruthers D; Damato EM; Denniston A; Hamburger J; Maxton C; Mitton D; Murray PI; Nightingale P; Poveda-Gallego A; Richards A; Whallett A; Situnayake D
BMC Musculoskelet Disord; 2017 Mar; 18(1):101. PubMed ID: 28283043
[TBL] [Abstract][Full Text] [Related]
31. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
32. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome.
Hamuryudan V; Fresko I; Direskeneli H; Tenant MJ; Yurdakul S; Akoglu T; Yazici H
Rheumatology (Oxford); 1999 Aug; 38(8):734-6. PubMed ID: 10501421
[TBL] [Abstract][Full Text] [Related]
35. New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.
Senusi A; Kang A; Buchanan JAG; Adesanya A; Aloraini G; Stanford M; Fortune F
Br J Oral Maxillofac Surg; 2020 Oct; 58(8):1034-1039. PubMed ID: 32819746
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of an electronic medical record-based disease activity index for Behçet's disease.
Kim DY; Choi MJ; Kim HY; Cho S; Cho SB; Bang D
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S40-4. PubMed ID: 25268661
[TBL] [Abstract][Full Text] [Related]
37. Is there a relation between clinical disease activity and acute phase response in Behcet's disease?
Melikoglu M; Topkarci Z
Int J Dermatol; 2014 Feb; 53(2):250-4. PubMed ID: 24261602
[TBL] [Abstract][Full Text] [Related]
38. The influence of oral health and psycho-social well-being on clinical outcomes in Behçet's disease.
Senusi A; Higgins S; Fortune F
Rheumatol Int; 2018 Oct; 38(10):1873-1883. PubMed ID: 30151720
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Syndrome in Behçets Disease Patients: Keep an Eye on the Eye.
ElAdle SS; Latif EA; Abdel-Fattah YH; Shebini EE; El-Gazzar II; El-Saadany HM; Samy N; El-Mallah R; Salem MN; Eesa N; Shereef RE; El Khalifa M; Tharwat S; Nasef SI; Ibrahim ME; Khalil NM; Abdalla AM; Abd Elazeem MI; Noor RA; Sallam R; El-Bahnasawy A; Shanawany AE; Senara S; Fathi HM; Bakry SAE; Elsaman A; Najjar AE; Ragab U; Talaat EA; Hammam N; El-Hindawy AK; Gheita TA; Ismail F
Curr Rheumatol Rev; 2023; 19(2):180-188. PubMed ID: 35692166
[TBL] [Abstract][Full Text] [Related]
40. Development of the BD-QoL: a quality of life measure specific to Behçet's disease.
Gilworth G; Chamberlain MA; Bhakta B; Haskard D; Silman A; Tennant A
J Rheumatol; 2004 May; 31(5):931-7. PubMed ID: 15124253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
